Needham, MA - ClinOne, a leading provider of patient engagement solutions for clinical trials, announced today the successful completion of a $3 million Series A funding round. The funding was led by Boulder Ventures, with participation from CU Healthcare Innovation Fund and First Trust Capital Partners.

ClinOne's founder, Andrea Valente, expressed excitement over the successful funding round, stating that the investment will help ClinOne continue to innovate and provide solutions that make a meaningful difference in the lives of patients and their families.

"By connecting patients, caregivers, and clinical trial sites with a true single platform for trial awareness, consent management, and patient engagement, ClinOne is changing the way clinical trials are conducted," Valente said. "We are grateful to our investors for their support and look forward to the next chapter of growth and innovation."

ClinOne's platform has been designed with participants and caregivers in mind, with a focus on ease of use and accessibility. The platform features the industry's fastest deployment, a cost-efficient scale for trials of all sizes, and seamless API integrations to provide the results patients need and the experience they deserve.